Eiger Biopharmaceuticals Stock Predictions

Healthcare > Biotechnology

Buy EIGR

*Your capital is at risk

$1.73

+0 (+0%)

At Close: Aug 27, 2024

Currently predicting for Fri, 5 Jun 2026

EIGR Prediction Chart

EIGR Predictions History

Latest community submissions for EIGR.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JS Pro	Jan 13, 2020	$13.60 -0.73%	$13.70	X	99.27%	4
NameNotImportant Pro	May 6, 2019	$10.37 -2.63%	$10.65	X	97.37%	0
NameNotImportant Pro	Apr 29, 2019	$10.91 -0.37%	$10.95	X	99.63%	4

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for EIGR with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT EIGER BIOPHARMACEUTICALS, INC.

Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to treat hepatitis delta virus infection. The company's product candidate also include Lambda, which targe...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by